SMAD3/4 Luciferase Reporter Lentivirus

The SMAD3/4 luciferase reporter lentivirus is a ready-to-use, replication-deficient lentiviral reporter system designed for highly sensitive quantitative detection of classic TGF-β pathway activity. Its core design places the luciferase gene under the control of a minimal promoter coupled to multiple SMAD binding elements (SBEs). These elements are recognized by SMAD3 complexed with SMAD4, ensuring reaction specificity and extremely low background signal. Lentiviral vector-mediated gene delivery enables stable genomic integration, resulting in persistent expression and facilitating the generation of stable, long-lasting reporter cell populations in various mammalian cell types, including those that are difficult to culture or divide slowly. The construct is built on a self-inactivating backbone, enhancing biosafety and transcriptional stability, and is optimized for standard luciferase substrates and luminometers, simplifying the detection process without requiring specialized equipment.

This reporter gene is ideal for dynamic monitoring of the TGF-β/Activin/Nodal signaling pathway, suitable for dose-response curve analysis, time-course analysis, and quantitative studies of pathway activation and inhibition in live cells or established reporter cell lines. It supports drug discovery and mechanism-of-action studies, allowing for rapid assessment of small molecule inhibitors or biologics targeting TGF-β receptors and downstream effector molecules, and is also valuable for ligand potency assays and comparability testing. In functional genomics research, this reporter gene facilitates the discovery of pathway regulators through CRISPR, RNAi, or overexpression screens, revealing cofactors, regulators, and pathway crosstalk nodes that influence SMAD3/4-driven transcription. Disease-related applications include modeling fibrotic signaling in the liver, lungs, kidneys, and cardiovascular system; studying epithelial-mesenchymal transition and tumor progression; evaluating stromal-tumor interactions in the tumor microenvironment; and investigating immunomodulation and tissue repair, where TGF-β is a key mediator.